Stay updated with breaking news from Pascal Deschatelets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) CEO Cedric Francois sold 30,000 shares of the company’s stock in a transaction dated Tuesday, March 21st. The shares were sold at an average price of $62.74, for a total transaction of $1,882,200.00. Following the completion of the transaction, the chief executive officer now directly owns 1,144,591 shares […]
Amalgamated Bank raised its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) by 5.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,172 shares of the company’s stock after acquiring an additional 772 shares during the period. Amalgamated Bank’s […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s stock price was up 3.1% during mid-day trading on Thursday . The company traded as high as $42.46 and last traded at $42.45. Approximately 19,657 shares traded hands during trading, a decline of 98% from the average daily volume of 1,062,128 shares. The stock had previously closed at […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) Director Alec Machiels sold 1,250 shares of Apellis Pharmaceuticals stock in a transaction dated Tuesday, March 15th. The stock was sold at an average price of $39.57, for a total transaction of $49,462.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which […]
WEEKEND READ | “These days, everything is so expensive." Many are getting frugal to make ends meet.